• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ACW 15.8% 3.2¢

ACTINOGEN MEDICAL LIMITED - Charts / Financials

Actinogen Medical Limited is an Australia-based biotechnology company. The Company is... Actinogen Medical Limited is an Australia-based biotechnology company. The Company is engaged in the development of a therapy for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol. The Company is engaged in the development of its lead compound, Xanamem, as a therapy for Alzheimer’s Disease, Major Depressive Disorder, Fragile X Syndrome, and other neurological diseases where reducing cortisol inside brain cells could have a positive impact. Xanamem’s mechanism of action is to block the production of cortisol inside cells through the inhibition of the 11B-HSD1 enzyme in the brain. Xanamem is designed to get into the brain after it is absorbed in the intestines upon swallowing its capsule. It has studied 11B-HSD1 inhibition by Xanamem in approximately 300 volunteers and patients. The Company conducts a series of Phase II studies in multiple diseases to further confirm and characterize Xanamem’s therapeutic potential.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

refresh Created with Sketch. REFRESH
Last update - 15.52pm 03/05/2024 (20 minute delay) ?
Day
Open 3.0¢   Day High 3.4¢   Day Low 2.9¢
Daily Volume 6157216
Bids   Sellers
Number Price Volume   Number Price Volume
2 3.2¢ 189149   4 3.4¢ 621429

Directors & Senior Management

Dr. Steven Gourlay Chief Executive Officer, Managing Director
Mr. William Souter Chief Financial Officer
Ms. Tamara Miller Senior Vice President - Product Development
Ms. Cheryl Townsend Vice President of Clinical Operations
Dr. Dana C. Hilt Chief Medical Officer
Prof. Paul Rolan Head - Clinical Pharmacology, Lead Physician - Depression
Ms. Therese Russell Head of People & Infrastructure
Dr. Christian Toouli Head of Business Development
Mr. Peter Gordon Webse Company Secretary
Dr. Geoffrey E. D. Brooke Non-Executive Chairman of the Board
Mr. Malcolm John Mccomas Non-Executive Director
Mr. George Morstyn Non-Executive Director
Dr. Nicki J. Vasquez Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
3.2¢
Change
-0.006(15.8%)
Mkt cap ! $74.46M
Open High Low Value Volume
3.0¢ 3.4¢ 2.9¢ $186.2K 6.157M

Buyers (Bids)

No. Vol. Price($)
2 189149 3.2¢
 

Sellers (Offers)

Price($) Vol. No.
3.4¢ 621429 4
View Market Depth
Last trade - 15.52pm 03/05/2024 (20 minute delay) ?
Last
3.2¢
  Change
-0.006 ( 11.1 %)
Open High Low Volume
3.0¢ 3.4¢ 2.9¢ 3278602
Last updated 15.52pm 03/05/2024 ?
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.